You are here: Home: Meet The Professors Live 1 | 2008: CME Information

Meet The Professors Live: Based on the proceedings of a live tumor panel discussion on the management of early and advanced breast cancer

OVERVIEW OF ACTIVITY

Breast cancer is one of the most rapidly evolving fields in medical oncology. Published results from ongoing clinical trials lead to the continuous emergence of new therapeutic agents and changes in the indications for existing treatments. To offer optimal patient care — including the option of clinical trial participation — practicing medical oncologists, hematologists and hematology-oncology fellows must be well informed of these advances. Meet The Professors Live uses relevant case-based discussions between community oncologists and clinical investigators to help practicing clinicians incorporate this information into evidence-based management strategies for treating breast cancer.

LEARNING OBJECTIVES

• Appraise the potential utility of genomic assays to aid in the quantification of risk and selection of individualized treatment for select patients with node-positive breast cancer.
• Devise an algorithm for the endocrine treatment of pre- and postmenopausal women with ER-positive early breast cancer, addressing total duration of therapy, management of side effects and concomitant use of bisphosphonates.
• Identify strategies to achieve local and systemic control of symptomatic inflammatory breast cancer.
• Recognize the impact of active pregnancy on the selection, timing and outcome of treatment for patients with early breast cancer.
• Compare and contrast the efficacy and safety of evidence-based combination regimens employed in the management of HER2-positive early and metastatic breast cancer.
• Appraise the clinical value of emerging adjuvant therapeutic approaches for triple-negative early breast cancer.
• Communicate the benefits and risks of the first-line use of bevacizumab for HER2-negative metastatic breast cancer.
• Counsel appropriately selected patients with breast cancer about participation in ongoing clinical trials.

ACCREDITATION STATEMENT

Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Research To Practice designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

HOW TO USE THIS CME ACTIVITY

This CME activity contains both audio and print components. To receive credit, the participant should review the CME information, listen to the audio and complete the Educational Assessment and Credit Form located on our website at ResearchToPractice.com/MTP/BreastLive. This monograph contains edited comments, clinical trial schemas, graphics and references that supplement the audio program. ResearchToPractice.com/MTP/BreastLive includes an easy-to-use, interactive version of this monograph with links to relevant full-text articles, abstracts, trial information and other web resources indicated here in blue underlined text.

This program is supported by educational grants from Abraxis BioScience, AstraZeneca Pharmaceuticals LP and Genentech BioOncology.